MDXHealth
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
30 jan 2008 - 08:18
Statutaire naam
MDXHealth
Titel
OncoMethylome Sciences SA to Initiate a Large Colorectal Cancer Clinical Trial and Acquire Minority Interest in Signature Diagnostics AG
Bericht
Liege (Belgium) – January 30, 2008, 8:00am CET – OncoMethylome Sciences (Euronext Brussels ONCOB, Euronext Amsterdam ONCOA) announced today that it plans to launch a large, international, multi-center colorectal cancer clinical trial. The German portion of the international trial will be managed by Signatures Diagnostics. Signature Diagnostics will receive an upfront payment plus service fees for its contribution to the clinical trial. In addition, both companies also agreed that OncoMethylome Sciences will obtain first negotiation rights on a test in development by Signature Diagnostics for predicting outcomes in colorectal cancer patients. Subject to certain conditions that are standard for this type of transactions, OncoMethylome Sciences also agreed to acquire a minority interest in Signature Diagnostics.
Additional details and financial terms of the agreement were not disclosed.
“Signature Diagnostics demonstrated that it is able to support a large, multi-center, prospective clinical trial in colorectal cancer with its trial technology. OncoMethylome plans to use this new trial for large-scale, international, validation of OncoMethylome’s blood test for colorectal cancer screening,” commented Herman Spolders, CEO of OncoMethylome Sciences. “In addition, the test in development by Signature Diagnostics complements our own product development pipeline; therefore, we are happy to obtain first negotiation rights on this potential product.”
“This financial commitment from OncoMethylome is a vote of confidence in our clinical programs and in our product development pipeline. We welcome OncoMethylome into our group of shareholders”, added Andre Rosenthal, CEO of Signature Diagnostics.
Gerelateerde downloads
Datum laatste update: 22 februari 2026